Novo Nordisk Posts Mixed Results, Adding to Jitters About Weight-Loss Drugs
A mixed sales report for Novo Nordisk’s GLP-1 megablockbuster drugs failed to quiet concerns Wednesday that investors may have overestimated the market for its new weight-loss and diabetes medicines.
FDA adds new warning to weight loss drugs including Wegovy
The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under anesthesia.
Medicaid covers GLP-1 weight-loss drugs in just 13 states
Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers said.
Map Shows States Where Weight Loss Drugs are Most Popular
Kentucky, Alaska and Alabama are the three states where weight loss drugs are most used, and Hawaii, Arizona and Colorado sit at the other end of the spectrum, a report has revealed. Glucagon-like peptide-1 (GLP-1) receptor analogs are drugs that mimic fullness hormone GLP-1 and have been shown to reduce appetite,
Novo Nordisk aware of reports 10 people taking compounded weight-loss drug copies died
Novo Nordisk said on Wednesday it was aware of reports of 10 deaths and 100 hospitalisations of people who had taken compounded copies of its weight-loss and diabetes drugs. U.S. regulations allow compounding pharmacies to copy brand-name medicines that are in short supply by combining,
New Atlas16h
Weight-loss pill passes important safety test in clinical trial
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
Outsourcing-pharma10d
Competitors race to launch GLP-1 drugs amid soaring weight loss demand
Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are ...
Medscape11d
GLP-1 Use Presurgery Safe but No Weight Loss Boost
Use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) prior to bariatric surgery was safe but wasn’t associated with ...
FOX13 Memphis10d
Most Patients Can Keep Using GLP-1 Weight Loss Meds Before Surgeries
A consortium of medical groups are now recommending that most patients who are taking a GLP-1 weight-loss or diabetes drugs ...
Smoothie King creates GLP-1 menu for weight loss drug users
Smoothie King says it is the first quick service restaurant brand with a GLP-1 focused menu.
GLP-1 receptor agonists linked to substantial muscle loss as part of weight loss process: Lancet
A recent commentary published in The Lancet journal highlights the critical importance of skeletal muscle mass in the context ...
4 Ways to Prevent Muscle Loss on Ozempic & Other Weight Loss GLP-1 Medications
You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...
From GLP-1 Drugs To Catastrophic Claims – Why Employer Health Premiums Are Skyrocketing In 2025
As open enrollment kicks off, employees may find an unpleasant surprise in their 2025 health insurance premiums. Increased adoption of GLP-1 drugs, rising catastrophic claims and other cost pressures ...